RAG1 and neoplasm: We then focused our analysis on the tumor samples taken at the same time point, day 23, for wild-type and RAG1−/− samples and considered neoantigens found both in the MC38 cell line and in at least one of the RAG1−/− tumors (Fig. 3e).